Envíos recientes

Mostrando ítems 21-25 de 10309

Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

2022- Martínez-Sanz, J.; Ron, R.; Moreno, E.; Sánchez-Conde, M.; Muriel, A.; [et al.]
SEOM-GEICO clinical guidelines on endometrial cancer (2021)

2022- Barretina-Ginesta, M.P.; Quindós Varela, María; Alarcón, J.D.; Esteban, C.; Gaba, L.; [et al.]
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

2022- Elberdín, L.; Fernández Torres, Rosa María; Paradela de la Morena, Sabela; Mateos, M.; Blanco, E.; [et al.]
Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

2022- Vázquez, R.; Díez-Martínez, R.; Domingo-Calap, P.; García, P.; Gutiérrez, D.; [et al.]
A Idade Materna Avançada como Fator de Risco Obstétrico: Experiência Atual num Hospital do Noroeste de Espanha

2022- Peteiro Mahía, Laura; Blanco López, Susana; López Castiñeira, Noelia; Navas-Arrebola, R.; Seoane-Pillado, T.; [et al.]